These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6709649)

  • 1. Sensitivity to corticosterone-induced cleft palate is not associated with H-2.
    Tyan ML
    Proc Soc Exp Biol Med; 1984 May; 176(1):14-21. PubMed ID: 6709649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CORT-GR signal transduction pathway and CORT-induced cleft palate in H-2 congenic mice.
    Jaskoll T; Choy HA; Chen H; Melnick M
    J Craniofac Genet Dev Biol; 1995; 15(2):57-65. PubMed ID: 7635930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoid-induced cleft palate in the mouse: two major histocompatibility complex, H-2, loci with different mechanisms.
    Bonner JJ; Tyan ML
    Genetics; 1983 Feb; 103(2):263-76. PubMed ID: 6832582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility to cleft palate and the major histocompatibility complex (H-2) in the mouse.
    Vekemans M; Fraser FC
    Teratology; 1982 Apr; 25(2):267-70. PubMed ID: 7101203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin A-enhanced cleft palate susceptibility gene maps between C4 and B144 within the H-2 complex.
    Tyan ML; Tyan DB
    Proc Soc Exp Biol Med; 1993 Apr; 202(4):482-6. PubMed ID: 8456115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleft palate susceptibility maps in two H-2 subregions, H-2K to I-B and G to H-2D.
    Bonner JJ; Tyan ML
    J Immunogenet; 1982 Aug; 9(4):243-8. PubMed ID: 6811666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin A-enhanced cleft palate susceptibility associated with H-2.
    Tyan ML
    J Immunogenet; 1987; 14(4-5):239-45. PubMed ID: 3454798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Backcross test demonstrates the linkage of glucocorticoid-induced cleft palate susceptibility to H-2.
    Bonner JJ; Tyan ML
    Teratology; 1982 Oct; 26(2):213-6. PubMed ID: 7157197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroid-induced cleft palate in mice and H-2 haplotype: maternal and embryonic effects.
    Melnick M; Jaskoll T; Slavkin HC
    Immunogenetics; 1981; 13(5):443-50. PubMed ID: 7197664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenytoin teratogenicity in the primary and secondary mouse embryonic palate is influenced by the H-2 histocompatibility locus.
    Goldman AS; Fishman CL; Baker MK
    Proc Soc Exp Biol Med; 1983 May; 173(1):82-6. PubMed ID: 6856622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrocortisone-induced embryotoxicity and embryonic drug disposition in H-2 congenic mice.
    Roberts LG; Hendrickx AG
    J Craniofac Genet Dev Biol; 1987; 7(4):341-56. PubMed ID: 3429612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relation between maternal restraint and food deprivation, plasma corticosterone, and induction of cleft palate in the offspring of mice.
    Barlow SM; McElhatton PR; Sullivan FM
    Teratology; 1975 Oct; 12(2):97-103. PubMed ID: 1198328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid-induced cleft palate genes in chromosome 17: genetic linkage and mapping analyses.
    Bonner JJ; Tyan ML
    Immunogenetics; 1984; 20(2):169-83. PubMed ID: 6469287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential role for corticosterone in the induction of cleft palate in mice after treatment with a selective NK-1 receptor antagonist, casopitant (GW679769B).
    Ziejewski MK; Solomon HM; Stanislaus D; Clark RL; White TE; Apostoli AR
    Birth Defects Res B Dev Reprod Toxicol; 2012 Feb; 95(1):54-62. PubMed ID: 22127931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinants in the H-2S/H-2D interval of mouse chromosome 17 define the map position of a gene for cleft palate susceptibility.
    Gasser DL; Yadvish KN; Trammell MA; Goldman AS
    Teratology; 1988 Dec; 38(6):571-7. PubMed ID: 3238613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a no-effect dose for corticosteroid-induced cleft palate? The contribution of endogenous corticosterone to the incidence of cleft palate in mice.
    Fawcett LB; Buck SJ; Beckman DA; Brent RL
    Pediatr Res; 1996 May; 39(5):856-61. PubMed ID: 8726241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of embryonic palatal shelf horizontalization and medial edge epithelial breakdown by cortisol: role of H-2 in the mouse.
    Goldman AS; Herold R; Piddington R
    J Craniofac Genet Dev Biol; 1988; 8(2):135-45. PubMed ID: 3182969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of teratogens on maternal corticosterone levels and cleft incidence in A/J mice.
    Sullivan-Jones P; Hansen DK; Sheehan DM; Holson RR
    J Craniofac Genet Dev Biol; 1992; 12(4):183-9. PubMed ID: 1494023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleft palate induction in hamster fetuses by glucocorticoid hormones and their synthetic analogues.
    Shah RM; Kilistoff A
    J Embryol Exp Morphol; 1976 Aug; 36(1):101-8. PubMed ID: 978122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of adenylate cyclase in perfusion mouse palate by secalonic acid D.
    Reddy RV; Eldeib MM; Reddy CS
    J Toxicol Environ Health; 1994 Feb; 41(2):175-85. PubMed ID: 8301697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.